Menu Search
Equities

Healthpeak Properties Inc

HC5:BER

Healthpeak Properties Inc

Actions
  • Price (EUR)20.80
  • Today's Change0.40 / 1.96%
  • Shares traded60.00
  • 1 Year change+43.45%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 16:18 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in and manage real estate focused on healthcare discovery and delivery. It has a diversified portfolio of high-quality healthcare properties across three core asset classes of lab, outpatient medical, and continuing care retirement community (CCRC) real estate. The Company’s segments include Lab, Outpatient medical and CCRC. The lab segment properties contain laboratory and office space, are leased primarily to biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Outpatient Medical segment includes outpatient medical buildings and hospitals. Outpatient medical buildings typically contain physicians’ offices and examination rooms.

  • Revenue in USD (TTM)2.56bn
  • Net income in USD308.77m
  • Incorporated2022
  • Employees193.00
  • Location
    Healthpeak Properties Inc4600 South Syracuse Street, Suite 500DENVER 80237United StatesUSA
  • Phone+1 (949) 407-0700
  • Websitehttps://www.healthpeak.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.